Cannabis Law Report

SEPTEMBER 10, 2021

integrates the latest developments in neuroscience and neurobiology to create a novel approach to mental health and well-being. is focused on the development, production, and marketing of psychedelic-based products, as legally permitted, with clinically proven efficacy. Dimensions Health Centres Inc. Xpira Pharmaceuticals Inc.

Research and Development 102

Research and Development Microdosing Pharmaceutical Education 102

Veriheal

MAY 13, 2022

has funneled her energy into simplifying the process of conducting psychedelic research. Well-funded psychedelics research programs that took place in the mid-20th century—all of which were carried out legally—hypothesized that controlled psilocybin use could offer a host of benefits for people with psychiatric problems. milligrams.

Research and Development 98

Research and Development Legalization Consumption Microdosing 98

Cannabis Law Report

JULY 13, 2022

The proposed phase I dosing study will aim to find the optimal microdose or low dose of psilocybin that provides general enhancements to mood, memory, sleep, and other measures of general well-being without any hallucinogenic effects. VANCOUVER, British Columbia, July 13, 2022 (GLOBE NEWSWIRE) — Optimi Health Corp. (

Therapy 52

Therapy Clinical Trials Microdosing Research and Development 52

The Cannigma

JUNE 24, 2021

These natural alternatives may also be effective as part of a daily “microdosing” regiment. In recent years, cannabis has been the subject of a tremendous amount of scientific research, and in 2020 there was a record number of scientific studies published on cannabis. Meditation and mindfulness. How CBD and cannabis products can help.

CBD 105

CBD Microdosing Edibles Sleep 105

Cannabis Law Report

AUGUST 10, 2022

Researchers will explore whether the psychoactive effects are necessary to relieve treatment-resistant depression in adults. It’s clear that alternative treatment options are necessary to combat depression and other mental illnesses, which is where companies developing psychedelic-based treatments like Optimi Health Corp.

Clinical Trials 52

Clinical Trials Research and Development Therapy Microdosing 52

Cannabis Law Report

MARCH 3, 2022

Vincent and the Grenadines (SVG) is looking to position itself as one of the most progressive countries on the planet for psychedelic research. . If everything works out in the production and research phase, there is a clause in the license that will allow it to be expanded to clinical trials. and Europe.

Research and Development 52

Research and Development Medicine Clinical Trials Microdosing 52

PrestoDoctor

JULY 14, 2020

For many people, treating anxiety with medical marijuana is an effective and safe treatment. If other treatments haven’t helped you, medical marijuana may be worth a try. Scientists don’t know the specific reasons why some people develop anxiety. Unfortunately, these treatments don’t work for everyone.

Marijuana 52

Marijuana Indica Strains Sativa 52

The Cannigma

JULY 3, 2023

The clues we have from existing literature indicate that while it’s probably safe, there’s insufficient clinical research to confirm or dispel it. Happily, the body of research into cannabis and psychedelics (including MDMA) is expanding fast, and it’s likely that better data on their interactions will become available in the near future.

Research and Development 61

Research and Development Environment THC Microdosing 61

Meadow

OCTOBER 17, 2017

There is still little research on cannabis to know how exactly it interacts with ADHD, but it could provide benefits similar to Adderall and Ritalin without the unpleasant side effects or withdrawal symptoms. At a younger age, a person has a higher risk of developing a problematic use of cannabis. That’s pretty great.

Law 40

Law Sleep Research and Development Patients 40

The Joint Blog

AUGUST 7, 2023

But there’s minimal clinical research specifically on delta 8 gummies for sleep yet. This may be from developing tolerance over time. However, clinical research on delta 8 gummies for increasing appetite and weight is non-existent currently. More research on delta 8’s specific effects is still needed.

Research and Development 26

Research and Development Sleep THC CBD 26

The Cannigma

DECEMBER 12, 2022

Now, psychedelic research is booming. And while most psychedelics are currently illegal in the United States and around the world, researchers are exploring their use in medicine to treat conditions such as depression, PTSD, addiction, anxiety, OCD, migraines, end of life acceptance of mortality, and eating disorders.

History 141

History Microdosing Research and Development Clinical Trials 141

Cannabis Law Report

JULY 9, 2022

For Jessica Thornton, who has lived with treatment-resistant depression since her senior year at high school, psychedelics represent a lifeline. Desperate to find any solution, she tried microdosing psilocybin mushrooms after researching the practice online. I felt as if I was in a constant battle with myself. I was just numb.

Microdosing 52

Microdosing Wellness and Beauty Research and Development Clinical Trials 52

Cannabis Law Report

SEPTEMBER 10, 2019

They write, “ At the Center for Psychedelic and Consciousness Research, researchers will focus on how psychedelics affect behavior, mood, cognition, brain function, and biological markers of health. The researchers hope to create precision medicine treatments tailored to the specific needs of individual patients.

Research and Development 45

Research and Development Microdosing Clinical Trials Decriminalization 45

SpeedWeed

MAY 22, 2021

Consider this an introductory crash course in the realm of neuroscience and psychedelic research. While the temporal quality of both EEG and MEG are remarkable, psychedelic research isn’t so much concerned about when a person’s trip begins and ends as it is about which parts of the brain are actually activating — the spatial accuracy.

Research and Development 52

Research and Development Microdosing Wellness and Beauty Pets 52

Project CBD

MAY 10, 2023

He told me he hadn’t read as much coverage of psychedelics in popular magazines and other mainstream outlets lately, and asked whether research has slowed. Mood-Elevating Microdosing Whether microdosing psychedelics can help people in meaningful ways independent of the placebo effect continues to be a subject of debate.

Microdosing 191

Microdosing Research and Development Treatment Therapy 191

Cannabis Law Report

JUNE 4, 2021

there has never been a better time for new treatment options. Scientific accomplishments (developments, discoveries, etc.). Psychedelic Invest’s intention with this publication is to raise awareness to a broader audience, in order to further develop the psychedelics ecosystem in a positive and sustainable manner.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51